The Next Web5d
Will AI revolutionise drug development? Researchers say it depends on how it’s used
A high drug failure rate is more than just a pattern recognition problem. Here's how we can address some of the root causes.
JD Supra11d
Rethinking FDA’s Accelerated Approval Pathway: New Draft Guidances and Implications for Drug Companies
The U.S. Food and Drug Administration (FDA) recently issued two new guidance documents governing details of the Accelerated Approval ...
Medscape15d
Lessons From an Undeveloped Drug
Significant organizational changes are necessary in order to embrace a model-based drug-development approach. The development pathway of new drugs seems to be disruptive, with little communication ...
Inflammation-triggering cellular pathway identified as potential new drug target for Alzheimer's disease
A team of researchers from the Keck School of Medicine of USC has unlocked the details of a cellular pathway that triggers ...
Hosted on MSN28d
Drug candidates target metabolic pathway in bacteria while sparing human cells
This principle is an important basis for the development of antibiotics ... If the MEP pathway in bacteria is blocked, for example by a drug, the bacteria can no longer produce a number of ...
Sydney Morning Herald5d
A small team of Australian scientists won a rare drug approval – and upended the pharma system
independent team of Australian scientists won a rare approval – upending the normal drug development pathway. The success of their audacious strategy paves the way for charities and not-for ...
Morningstar14d
Genialis Advances Biomarker Discovery to Reduce Risk in Cancer Drug Development Targeting DNA Damage Response Pathways
Extending their collaboration, Genialis and Debiopharm continue working towards a patient classifier to support WEE1 clinical development ... landscape of cancer drug targets, including DDR.
Business Wire13d
Genialis Advances Biomarker Discovery to Reduce Risk in Cancer Drug Development Targeting DNA Damage Response Pathways
DDR is a promising arena for the development of precision medicines ... of biomarkers across the entire landscape of cancer drug targets, including DDR. Trained on hundreds of thousands of ...